MTOR and autosomal dominant polycystic kidney disease: Based on these findings and our previous experimental work, we hypothesized that mTOR inhibition might also lead to compensatory up-regulation of the PI3K-dependent pathway in ADPKD by the release of mTOR controlled negative feedback loops that may attenuate the efficacy of mTOR inhibitors.